Evidence map›Paper›PMID 32366721›Full record

ArticleAntimicrobial agents and chemotherapy2020

Comparative Genomic Analysis of Third-Generation-Cephalosporin-Resistant Escherichia coli Harboring the

Takahiro Shirakawa, Tsuyoshi Sekizuka, Makoto Kuroda, Satowa Suzuki, Manao Ozawa, Hitoshi Abo, Yukari Furuya, Ryoko Akama, Mari Matsuda, Yoko Shimazaki and 2 more

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Detection of ESBL-producingFrontiers in microbiology · 2025
    Article
  3. Article
  4. Article
  5. A nationwide survey of antimicrobial resistance ofJAC-antimicrobial resistance · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Higher prevalence of CTX-M-27-producing Escherichia coli belonging to ST131 clade C1 among residents of two long-term care facilities in Southern Spain.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Article
  11. Frontiers in microbiology · 2022
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Takahiro ShirakawaAssay Division II, Safety Assay Section I, National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan takahiro_shirakaw140@maff.go.jp.
Tsuyoshi SekizukaPathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
Makoto KurodaPathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
Satowa SuzukiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Manao OzawaAssay Division II, Safety Assay Section I, National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan.
Hitoshi AboAssay Division II, Safety Assay Section I, National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan.
Yukari FuruyaAssay Division II, Safety Assay Section I, National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan.
Ryoko AkamaAssay Division II, Safety Assay Section I, National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan.
Mari MatsudaAssay Division II, Safety Assay Section I, National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan.
Yoko ShimazakiAssay Division II, Safety Assay Section I, National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan.
Mayumi KijimaAssay Division II, Safety Assay Section I, National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan.
Michiko KawanishiAssay Division II, Safety Assay Section I, National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan.
Ministry of Agriculture, Forestry and Fisheries · JPNational Institute of Infectious Diseases · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The off-label use of third-generation cephalosporins (3GCs) during

Indexed as

Escherichia coliEscherichia coli InfectionsAnimalsAnti-Bacterial Agentsbeta-LactamasesCephalosporinsChickensEuropeGenomicsGermanyJapanMultilocus Sequence TypingNorth AmericaPhylogenyPlasmidsAnti-Bacterial Agentsbeta-lactamase CMY-2beta-LactamasesCephalosporinsblaCMY-2broilercephalosporinoff-label useplasmids

Identifiers

PMID32366721
PMCPMC7318016
OpenAlexW3021600509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.